Abstract
Abstract
Background
Mass drug administration is one of the key interventions recommended by WHO to control certain NTDs. With most support from donors, health workers distribute antihelminthic drugs annually in Malawi. Mean community coverage of MDA from 2018 to 2020 was high at 87% for praziquantel and 82% for albendazole. However, once donor support diminishes sustaining these levels will be challenging. This study intended to compare the use of the community-directed intervention approach with the standard practice of using health workers in delivery of MDA campaigns.
Methods
This was a controlled implementation study carried out in three districts, where four health centres and 16 villages in each district were selected and randomly assigned to intervention and control arms which implemented MDA campaigns using the CDI approach and the standard practice, respectively. Cross-sectional and mixed methods approach to data collection was used focusing on quantitative data for coverage and knowledge levels and qualitative data to assess perceptions of health providers and beneficiaries at baseline and follow-up assessments. Quantitative and qualitative data were analyzed using IBM SPSS software version 26 and NVivo 12 for Windows, respectively.
Results
At follow-up, knowledge levels increased, majority of the respondents were more knowledgeable about what schistosomiasis was (41%-44%), its causes (41%-44%) and what STH were (48%-64%), while knowledge on intermediate host for schistosomiasis (19%-22%), its types (9%-13%) and what causes STH (15%-16%) were less known both in intervention and control arm communities. High coverage rates for praziquantel were registered in intervention (83%-89%) and control (86%-89%) communities, intervention (59%-79) and control (53%-86%) schools. Costs for implementation of the study indicated that the intervention arm used more resources than the control arm. Health workers and community members perceived the use of the CDI approach as a good initiative and more favorable over the standard practice.
Conclusions
The use of the CDI in delivery of MDA campaigns against schistosomiasis and STH appears feasible, retains high coverages and is acceptable in intervention communities. Despite the initial high costs incurred, embedding into community delivery platforms could be considered as a possible way forward addressing the sustainability concern when current donor support wanes.
Trial registration
Pan-African Clinical Trials Registry PACTR202102477794401, date: 25/02/2021.
Funder
Bill and Melinda Gates Foundation
Foreign, Commonwealth and Development Office
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Makaula P, Sadalaki JR, Muula AS, Kayuni S, Jemu SK, Bloch P. Schistosomiasis in Malawi: a systematic review. Parasit Vectors. 2014;7:570.
2. Malawi Government. Ministry of Health master plan for neglected tropical diseases (NTD) for Malawi 2015–2020. Lilongwe: Ministry of Health and Population; 2015.
3. Ministry of Health and Population, National Schistosomiasis and STH Control Programme. Reports of 2018 - 2020 MDA Campaigns. Lilongwe: Malawi; 2018, 2019 and 2020.
4. Makaula P, Kayuni SA, Mamba KC, Bongololo G, Funsanani M, Musaya J, et al. An assessment of implementation and effectiveness of mass drug administration for prevention and control of schistosomiasis and soil-transmitted helminths in selected southern Malawi districts. BMC Health Serv Res. 2022;22:517.
5. World Health Organization. Special Programme for Research and Training in Tropical Diseases. Community-directed interventions for major health problems in Africa: a multi-country study final report. 2008.